Open AccessReal-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2– patients with metastatic breast cancer
Author(s) -
Jingping Li,
Xiangmei Zhang,
Chao Yang,
Yalei Lv,
Hua Yang,
Xiangshun Kong,
Meng Han,
Zunyi Wang,
Jie Ma,
Jianjun Han,
Yunjiang Liu
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000027710
Subject(s) - palbociclib , medicine , metastatic breast cancer , oncology , clinical endpoint , neutropenia , breast cancer , progression free survival , proportional hazards model , univariate analysis , cancer , multivariate analysis , chemotherapy , clinical trial